
Trueglipt M 500mg/20mg Tablet ER
Marketer
Biospark Pharmaceuticals And Laboratories Pvt Ltd
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Trueglipt M 500mg/20mg Tablet ER
Metformin/Linagliptin 500mg/20mg Extended-Release tablets manage elevated blood glucose in patients with type 2 diabetes. This dual-action therapy mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the probability of cardiovascular events like stroke or myocardial infarction. This medication can be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician supervision. Effective blood sugar management helps prevent future complications. Maintaining the prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes control. Common adverse effects include nausea, vomiting, diarrhea, abdominal distress, and cephalalgia. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; learn to recognize and manage this condition. This medication isn't universally appropriate. Inform your physician of any pre-existing kidney, liver, or cardiac conditions, pancreatic issues, or significant alcohol consumption before initiating therapy. Pregnant or lactating individuals should seek medical counsel. Interactions with other medications are possible; disclose all medications to your doctor for safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout your treatment.
Uses of Trueglipt M 500mg/20mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Trueglipt M 500mg/20mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 500mg/20mg Trueglipt M Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Trueglipt M 500mg/20mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Trueglipt M 500mg/20mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Trueglipt M 500mg/20mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Trueglipt M 500mg/20mg Tablet ER works:
Extended-release Trueglipt M tablets (500mg/20mg) contain a dual antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Trueglipt M 500mg/20mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Trueglipt M 500mg/20mg tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Trueglipt M 500mg/20mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Trueglipt M 500mg/20mg Tablet ER on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Trueglipt M 500mg/20mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Trueglipt M 500mg/20mg Extended-Release tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverUNSAFE
Individuals with liver impairment should likely not take Trueglipt M 500mg/20mg Extended-Release tablets; medical advice is recommended.
What if you forget to take Trueglipt M 500mg/20mg Tablet ER :
Should you forget a Trueglipt M 500mg/20mg Extended-Release tablet, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trueglipt M 500mg/20mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
